Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-10-08 00:00:00 ET · period of report 2025-10-06 · accession 0001695028-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-08 | 2025-10-06 | ORIC | Piscitelli Dominic | CFO | S - Sale+OE | $14.52 | -11.0K | 48.3K | -19% | -$159.7K |
| D | 2025-10-08 | 2025-10-06 | ORIC | Piscitelli Dominic | CFO | M - OptEx | $4.36 | +11.0K | 59.3K | +23% | +$48.0K |
| D | 2025-10-08 | 2025-10-06 | ORIC | Piscitelli Dominic | CFO | M - OptEx | $0.00 | -11.0K | 196.5K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-06 | S | D | 11,000 | $14.52 | 48,317 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 11,000 shares sold in the price range of $14.50 to $14.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-10-06 | M | A | 11,000 | $4.36 | 59,317 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-10-06 | M | D | 11,000 | $0.00 | 196,500 | D | $4.36 · 2025-07-20 to 2032-07-19 | 11,000 Common Stock |